Huons Global Co., Ltd. (KOSDAQ:084110)

South Korea flag South Korea · Delayed Price · Currency is KRW
45,200
+200 (0.44%)
Jun 27, 2025, 3:30 PM KST
85.63%
Market Cap 592.56B
Revenue (ttm) 810.68B
Net Income (ttm) 26.03B
Shares Out 12.18M
EPS (ttm) 2,134.05
PE Ratio 22.80
Forward PE n/a
Dividend 525.00 (1.06%)
Ex-Dividend Date Jun 27, 2025
Volume 34,035
Average Volume 59,660
Open 45,000
Previous Close 45,000
Day's Range 43,950 - 45,600
52-Week Range 20,500 - 54,900
Beta 1.07
RSI 41.63
Earnings Date Aug 1, 2025

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami... [Read more]

Sector Healthcare
Founded 1965
Employees 121
Stock Exchange KOSDAQ
Ticker Symbol 084110
Full Company Profile

Financial Performance

In 2024, Huons Global's revenue was 813.46 billion, an increase of 7.26% compared to the previous year's 758.38 billion. Earnings were 25.79 billion, a decrease of -32.81%.

Financial Statements

News

There is no news available yet.